Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 4/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20849310 | 1.00 | AR (0.31) | ARGRIN1GRIN2BPPARGPPARA | |
| SCHEMBL20849274 | 0.94 | ICMT (0.32) | ARGRIN1GRIN2B | |
| SCHEMBL20848990 | 0.93 | KIF11 (0.33) | ARGRIN1GRIN2BPPARGPPARA | |
| SCHEMBL20849296 | 0.92 | TACR1 (0.33) | GRIN1GRIN2B | |
| SCHEMBL20849301 | 0.91 | KDM4E (0.32) | PPARGPPARA | |
| SCHEMBL20849312 | 0.91 | TACR1 (0.35) | ARGRIN1GRIN2B | |
| SCHEMBL20849273 | 0.91 | PTPN5 (0.34) | ARGRIN1GRIN2B | |
| SCHEMBL21399301 | 0.91 | KIF11 (0.33) | ARGRIN1GRIN2BPPARGPPARA | |
| SCHEMBL20849272 | 0.90 | AR (0.34) | ARGRIN1GRIN2B | |
| SCHEMBL20849221 | 0.90 | TACR1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10978646-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-04-13 | — | — | US | disclosed |
| US-20190097141-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10978646-B2 | Organic molecules for use in optoelectronic devices | OCIAD2, OCIAD1, POU2F1 | AR 3706/4885GRIN1 4149/4885GRIN2B 1746/4885 |
| US-20190097141-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OCIAD2, OCIAD1, POU2F1 | AR 3706/4885GRIN1 4149/4885GRIN2B 1746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.